Question 1

What is Altamira Therapeutics Ltd. (CYTOF)'s latest operating cash flow?

Accepted Answer

Altamira Therapeutics Ltd. (CYTOF)'s operating cash flow for FY2024 was -$6.1M, as reported in its SEC filings.

Question 2

How has Altamira Therapeutics Ltd. (CYTOF)'s operating cash flow changed year over year?

Accepted Answer

CYTOF's operating cash flow went from -$12.8M in FY2023 to -$6.1M in FY2024, an increase of 52.3%.

Question 3

What is the highest operating cash flow Altamira Therapeutics Ltd. (CYTOF) reported over FY2022–FY2024?

Accepted Answer

The highest reported operating cash flow over FY2022–FY2024 was -$6.1M, in FY2024.

Question 4

What years does this operating cash flow history cover?

Accepted Answer

This page shows CYTOF's operating cash flow for each fiscal year from FY2022 to FY2024, drawn from SEC XBRL filings.

Altamira Therapeutics Ltd. (CYTOF) Operating cash flow 2022–2024

More CYTOF financial trends